GE’s SPECT System Gets FDA Clearance

Article

GE Healthcare’s advanced single head nuclear medicine gamma camera with SPECT capability has received FDA clearance.

GE Healthcare’s advanced single head nuclear medicine gamma camera with SPECT capability has received FDA clearance, the company announced.

The Brivo NM615, designed as a cost-effective way to perform routine scanning while expanding their capabilities, allows doctors to lower injected patient dose by up to 50 percent of those of standard nuclear medicine scanning protocols, or the potential for patients to spend less time on the exam table, without compromising image quality, according to the company.

The system has a 70 cm wide bore and table capable of handling patients up to 500 pounds. The Brivo NM 615 can also be upgraded on site to the GE Healthcare Discover NM630 or the Discovery NM/CT 670 SPECT/CT hybrid systems. As a result, the system may expand the capability to serve patients in the future at faster speeds and with SPECT/CT hybrid scans.

Brivo NM615 can be used with the advanced Xeleris workstation, which integrates new and existing nuclear medicine equipment, including legacy GE and non-GE devices.

 

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.